Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-20-013987
Filing Date
2020-12-30
Accepted
2020-12-30 07:29:57
Documents
1
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 ASTRAZENECA'S COVID-19 VACCINE AUTHORISED IN UK a1114k.htm 6-K 34595
  Complete submission text file 0001654954-20-013987.txt   35752
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 201424007
SIC: 2834 Pharmaceutical Preparations